Profund Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $271K | Sell |
|
|||||
|
2025
Q2 | $293K | Sell |
|
|||||
|
2025
Q1 | $345K | Buy |
|
|||||
|
2024
Q4 | $221K | Sell |
|
|||||
|
2024
Q3 | $267K | Buy |
|
|||||
|
2024
Q2 | $302K | Buy |
|
|||||
|
2024
Q1 | $244K | Sell |
|
|||||
|
2023
Q4 | $371K | Sell |
|
|||||
|
2023
Q3 | $376K | Buy |
|
|||||
|
2023
Q2 | $394K | Sell |
|
|||||
|
2023
Q1 | $423K | Buy |
|
|||||
|
2022
Q4 | $232K | Sell |
|
|||||
|
2022
Q3 | $335K | Sell |
|
|||||
|
2022
Q2 | $388K | Sell |
|
|||||
|
2022
Q1 | $562K | Buy |
|
|||||
|
2021
Q4 | $435K | Buy |
|
|||||
|
2021
Q3 | $397K | Sell |
|
|||||
|
2021
Q2 | $487K | Buy |
|
|||||
|
2021
Q1 | $524K | Sell |
|
|||||
|
2020
Q4 | $484K | Buy |
|
|||||
|
2020
Q3 | $378K | Sell |
|
|||||
|
2020
Q2 | $350K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $330K | Sell |
|
|||||
|
2019
Q3 | $284K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $266K | Sell |
|
|||||
|
2018
Q3 | $440K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $292K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $365K | Buy |
|
|||||
|
2015
Q1 | $449K | Buy |
|
|||||
|
2014
Q4 | $407K | Buy |
|
|||||
|
2014
Q3 | $418K | Buy |
|
|||||
|
2014
Q2 | $255K | Buy |
|